Price, performance, and the FDA approval process: The example of home HIV testing

Medical Decision Making

Volumn 30, Issue 2, 2010, Pages 217-223

  Paltiel, A David ^a   Pollack, Harold A ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b The University of Chicago   (United States)

Author keywords

FDA; HIV testing; Predictive value

Indexed keywords

ANALYTICAL EQUIPMENT; ARTICLE; FOOD AND DRUG ADMINISTRATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ORGANIZATION AND MANAGEMENT; PREDICTION AND FORECASTING; SAFETY; UNITED STATES;

DEVICE APPROVAL; HIV INFECTIONS; HUMANS; PREDICTIVE VALUE OF TESTS; REAGENT KITS, DIAGNOSTIC; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 77950615624     PISSN: 0272989X     EISSN: 1552681X     Source Type: Journal    
DOI: 10.1177/0272989X09334420     Document Type: Article

References (36)

1. Approaches to Over-the-Counter Home-Use HIV Test Kits. Gaithersburg, MD: FDA Blood Products Advisory Committee ; 2005.
2. Centers for Disease Control and Prevention (CDC). Current CLIA Regulations. Available from: http://www.n.cdc.gov/clia/regs/toc.aspx
3. Delaney KP, Branson BM, Uniyal A., et al. Performance of an oral fluid rapid HIV-1/2 test: experience from four CDC studies. AIDS. 2006 ; 20: 1655-1660.
4. Buchér JB, Thomas KM, Guzman D., Riley E., Dela Cruz N., Bangsberg DR Community-based rapid HIV testing in homeless and marginally housed adults in San Francisco. HIV Med. 2007 ; 8: 28-31.
5. Landrum ML, Wilson CH, Perri LP, Hannibal SL, OConnell RJ Usefulness of a rapid human immunodeficiency virus-1 antibody test for the management of occupational exposure to blood and body fluid. Infect Control Hosp Epidemiol. 2005 ; 26: 768-774.
6. Bauserman RL, Ward MA, Eldred L., Swetz A. Increasing voluntary HIV testing by offering oral tests in incarcerated populations. Am J Public Health. 2001 ; 91: 1226-1229.
7. Doyle NM, Levison JE, Gardner MO Rapid HIV versus enzyme-linked immunosorbent assay screening in a low-risk Mexican American population presenting in labor: a cost-effectiveness analysis. Am J Obstet Gynecol. 2005 ; 193: 1280-1285.
8. Liang TS, Erbelding E., Jacob CA, et al. Rapid HIV testing of clients of a mobile STD/HIV clinic. AIDS Patient Care STDS. 2005 ; 19: 253-257.
9. OraSure Technologies, Inc. 2007 Annual Report. Available from: http://library.corporate-ir.net/library/99/997/99740/items/296916/OSUR0710K.pdf
10. http://www.fda.gov/ohrms/dockets/ac/05/slides/2005-4190s1.htm
11. http://www.fda.gov/ohrms/dockets/ac/06/transcripts/2006-4206t2.pdf
12. Walensky RP, Paltiel AD. Rapid HIV testing at home: does it solve a problem or create one? Ann Intern Med. 2006;145:459-62.
13. 13. Altman DG, Bland JM. Diagnostic tests 2: predictive values. BMJ. 1994;309:102.
14. Hlatky MA, Pryor DB, Harrell FE, Califf RM, Mark DB, Rosati RA Factors affecting sensitivity and specificity of exercise electorcardiography. Am J Med. 1984 ; 77: 64-71.
15. Hargreaves JR Socioeconomic status and risk of HIV infection in an urban population in Kenya. Trop Med Int Health. 2002 ; 7: 793-802.
16. Wojcicki JM Socioeconomic status as a risk factor for HIV infection in women in East, Central and Southern Africa: a systematic review. J Biosoc Sci. 2005 ; 37: 1-36.
17. Gillespie S., Kadiyala S., Greener R. Is poverty or wealth driving HIV transmission ? AIDS. 2007 ; 21: S5-16.
18. Diaz T., Chu SY, Buehler JW, et al. Socioeconomic differences among people with AIDS: results from a multistate surveillance project. Am J Prev Med. 1994 ; 10: 217-222. (Pubitemid 24302884)
19. McQuillan GM, Kruszon-Moran D., Kottiri BJ, et al. Prevalence of HIV in the US household population: the National Health and Nutrition Examination Surveys, 1988 to 2002. J Acquir Immune Defic Syndr. 2006 ; 41: 651-656.
20. Kaiser Family Foundation. HIV/AIDS Policy Fact Sheet: Black Americans and HIV/AIDS. July 2007. Available from: http://www.kff.org/hivaids/upload/6089-04. pdf
21. Brown NC, Taylor ED, Mulatu MS, Scott W. Demographic correlates of HIV testing, high-risk behaviors, and condom/STD consultation among a multi-ethnic sample of women. Women Health. 2007 ; 46 (2-3). 59-76.
22. Varian HR Microeconomic Analysis. 2 nd ed. New York: W. W. Norton ; 1984.
23. Chou R., Huffman LH, Fu R., Smits AK, Korthuis PT Screening for HIV: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2005 ; 143: 55-73.
24. World Health Organization. HIV/AIDS diagnostics. Available from: http://www.who.int/hiv/amds/diagnostics/en/index.html25. Health Research and Educational Trust. Charts Comparing Rapid HIV Antibody Screening Tests. Available from: http://www.hret.org/hret/programs/hivtransmrpd.html
25. Centers for Disease Control and Prevention. False-positive oral fluid rapid HIV tests-New York City, 2005-2008. MMWR. 2008 ; 57: 660-665.
26. OraSure Technologies, Inc. OraQuick Advance rapid HIV-1/2 antibody test [package insert]. Bethlehem, PA: Orasure Technologies ; 2004. Available from: http://www.fda.gov/CBER/pmalabel/P010047LB.pdf
27. Centers for Disease Control and Prevention. New Estimates of U.S. HIV Prevalence, 2006. Available from: http://www.cdc.gov/hiv/topics/surveillance/ resources/factsheets/prevalence.htm
28. Centers for Disease Control and Prevention. Revised guidelines for HIV counseling, testing, and referral. MMWR. 2001 ; 50: 1-58.
29. Centers for Disease Control and Prevention. Cases of HIV infection and AIDS in the United States, 2004. HIV/AIDS Surveillance Report. 2005 ; 16: 16-45.
30. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, 2006. Vol. 18. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention ; 2008. Available from: http://www.cdc.gov/ hiv/topics/surveillance/resources/reports/
31. Holmberg SD The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. Am J Public Health. 1996 ; 86: 642-654.
32. Seage GR III, Holte S., Metzger D., et al. The HIVNET Vaccine Preparedness Study (VPS): are United States populations appropriate for HIV vaccine trials? Am J Epidemiol. 2001 ; 153: 619-627.
33. St. Louis ME, Conway GA, Hayman CR, Miller C., Petersen LR, Dondero TJ Human immunodeficiency virus infection in disadvantaged adolescents: findings from the US Job Corps. JAMA. 1991 ; 266: 2387-2391.
34. Spielberg F., Branson BM, Goldbaum GM, et al. Overcoming barriers to HIV testing: preferences for new strategies among clients of a needle exchange, a sexually transmitted disease clinic, and sex venues for men who have sex with men. J Acquir Immune Defic Syndr. 2003 ; 32: 318-327.
35. Weiss Smith S. Sidelining safety: the FDAs inadequate response to the IOM. N Engl J Med. 2007 ; 357: 960-963.
36. Paltiel AD, Walensky RP, Schackman BR, et al. Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs. Ann Intern Med. 2006 ; 145: 797-806.